EXPERT OPINION ON THERAPEUTIC TARGETS
期刊信息导读
- EXPERT OPINION ON THERAPEUTIC TARGETS基本信息
- EXPERT OPINION ON THERAPEUTIC TARGETS中科院SCI期刊分区
- 历年EXPERT OPINION ON THERAPEUTIC TARGETS影响因子趋势图
- EXPERT OPINION ON THERAPEUTIC TARGETS期刊英文简介
- EXPERT OPINION ON THERAPEUTIC TARGETS期刊中文简介
EXPERT OPINION ON THERAPEUTIC TARGETS基本信息
简称：EXPERT OPIN THER TAR
中文名称：关于治疗目标的专家意见
研究方向：医学
2018-2019最新影响因子：4.621
SCI类别：SCIE
是否OA开放访问：No
出版地：ENGLAND
出版周期：Monthly
创刊年份：2001
年文章数：90
涉及的研究方向：医学-药学
通讯方式：INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ
官方网站：http://www.tandfonline.com/loi/iett20#.V48c20z9cSQ
投稿网址：https://mc.manuscriptcentral.com/eott
审稿速度：偏慢,4-8周
平均录用比例:一般
PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1472-8222%5BISSN%5D
EXPERT OPINION ON THERAPEUTIC TARGETS期刊英文简介
Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1472-8222.Expert Opinion on Therapeutic Targets is the premier journal dedicated to in-depth reports and reviews of the latest developments in the field of drug target discovery and validation. Expert Opinion on Therapeutic Targets is a peer-reviewed journal providing evaluated and expert reviews of recent research identifying novel molecular drug targets. The journal provides an essential link between basic research on biological pathways and interactions, and the development of the drugs of tomorrow. It is distinguished from other publications by its high-quality authorship and expertly drafted articles which are structured to incorporate the author's own expertise on the subject. The audience consists of scientists, managers and decision makers in the pharmaceutical industry, and others closely involved in R&D. Subscribers include most of the major pharmaceutical companies in the USA, Europe and Japan, as well as many biotechnology companies.
EXPERT OPINION ON THERAPEUTIC TARGETS期刊中文简介
由Informa Pharmaceutical Science出版(原Ashley Publications)。ISSN: 1472 - 8222。《治疗靶标的专家意见》是一本致力于深入报道和评论药物靶标发现和验证领域最新进展的权威杂志。《治疗靶标的专家意见》是一份同行评议的期刊，提供对最近发现新的分子药物靶标的研究的评估和专家评议。该杂志提供了生物途径和相互作用的基础研究与未来药物开发之间的重要联系。它与其他出版物的不同之处在于其高质量的作者和专业起草的文章，这些文章的结构吸收了作者自己在这个问题上的专业知识。观众包括制药行业的科学家、经理和决策者，以及与研发密切相关的其他人。用户包括美国、欧洲和日本的大多数主要制药公司，以及许多生物技术公司。
中科院SCI期刊分区：
| 大类学科 |
分区 |
小类学科 |
分区 |
Top期刊 |
综述期刊 |
| 医学 |
2区 |
PHARMACOLOGY & PHARMACY
药学
|
2区
|
否 |
是 |
EXPERT OPINION ON THERAPEUTIC TARGETS影响因子
获取相关优质资源获取2023中科院分区
![goback](data:image/svg+xml;charset=utf-8,<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 20"><path d="M10,0l2,2l-8,8l8,8l-2,2L0,10L10,0z" fill="%23fff"/></svg>){kind=icon}
